BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
First Trust Value Line Dividend Fund
FVD
$8.32B
| $242K | ﹤0.01% |
6,085
-11
| -0.2% | -$437 |
|
4677
Vanguard Dividend Appreciation ETF
VIG
$111B
| $242K | ﹤0.01% |
1,565
+51
| +3% | +$7.83K |
|
4678
Ramaco Resources Class A
METC
$599M
| $241K | ﹤0.01% |
45,478
+7,964
| +21% | +$38K |
|
4679
Smith-Midland
SMID
$144M
| $241K | ﹤0.01% |
+10,224
| New | +$162K |
|
4680
Beasley Broadcasting Group
BBGI
$37.8M
| $240K | ﹤0.01% |
4,149
-39
| -0.9% | -$2.17K |
|
4681
Nephros
NEPH
$36.8M
| $238K | ﹤0.01% |
23,474
-85
| -0.4% | -$709 |
|
4682
Schwab US REIT ETF
SCHH
$11.5B
| $238K | ﹤0.01% |
10,398
-350
| -3% | -$7.78K |
|
|
CNTG
4683
DELISTED
Centogene N.V. Common Shares
CNTG
| $236K | ﹤0.01% |
22,552
-410,716
| -95% | -$4.32M |
|
4684
Protalix BioTherapeutics
PLX
$191M
| $234K | ﹤0.01% |
122,499
+121,128
| +8,835% | +$417K |
|
|
SVM
4685
Silvercorp Metals
SVM
$2.07B
| $234K | ﹤0.01% |
42,602
-25,553
| -37% | -$148K |
|
|
ARDS
4686
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
| $234K | ﹤0.01% |
31,613
+5,232
| +20% | +$32.7K |
|
|
CHRA
4687
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| $234K | ﹤0.01% |
4,639
+638
| +16% | +$36.6K |
|
4688
Live Ventures
LIVE
$29.8M
| $231K | ﹤0.01% |
3,751
+3,120
| +494% | +$137K |
|
4689
ENDRA Life Sciences
NDRA
$5.97M
| $231K | ﹤0.01% |
+3
| New | +$236K |
|
|
GFED
4690
DELISTED
Guaranty Federal Bancshares In
GFED
| $229K | ﹤0.01% |
9,404
+7,917
| +532% | +$190K |
|
4691
Barnwell Industries
BRN
$14.8M
| $227K | ﹤0.01% |
68,867
-13,199
| -16% | -$37.6K |
|
4692
Processa Pharmaceuticals
PCSA
$5.95M
| $226K | ﹤0.01% |
+55
| New | +$213K |
|
4693
vTv Therapeutics
VTVT
$127M
| $224K | ﹤0.01% |
2,447
-9,461
| -79% | -$958K |
|
4694
ReWalk Robotics
LFWD
$20.3M
| $224K | ﹤0.01% |
+1,571
| New | +$245K |
|
|
EVOK
4695
DELISTED
Evoke Pharma
EVOK
| $221K | ﹤0.01% |
1,116
+68
| +6% | +$14.6K |
|
|
PPSI
4696
Pioneer Power Solutions
PPSI
$32.3M
| $216K | ﹤0.01% |
46,249
+4,108
| +10% | +$17K |
|
|
BKSC
4697
DELISTED
Bank of South Carolina
BKSC
| $213K | ﹤0.01% |
10,425
+8,600
| +471% | +$177K |
|
4698
RCM Technologies
RCMT
$201M
| $212K | ﹤0.01% |
51,556
+25,311
| +96% | +$93K |
|
4699
Ranger Energy Services
RNGR
$376M
| $212K | ﹤0.01% |
26,415
-20,231
| -43% | -$136K |
|
|
VOLT
4700
DELISTED
Volt Information Sciences, Inc.
VOLT
| $212K | ﹤0.01% |
46,267
+38,203
| +474% | +$153K |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.